Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target

Livia Salmi1, Francesco Gavelli1, Filippo Patrucco1

  • 1Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.

Disease Markers
|September 6, 2019
PubMed

Insights

The Gas6/TAM signaling pathway is crucial for maintaining homeostasis and regulating inflammation. This review explores its role in sepsis and septic shock, highlighting Gas6 as a potential biomarker and therapeutic target.

Area of Science:

  • Cellular Biology
  • Molecular Medicine
  • Immunology

Background:

  • Tyrosine kinase receptors, including the TAM family (Tyro 3, Axl, Mer), are key in cell signaling.
  • The TAM family shares a common ligand, growth arrest-specific 6 (Gas6), influencing physiological and pathological processes.
  • Dysregulation of the Gas6/TAM axis is implicated in various diseases due to their widespread tissue distribution.

Purpose of the Study:

  • To review current knowledge on the role of TAM receptors and Gas6 in clinical conditions.
  • To highlight recent discoveries concerning the Gas6/TAM axis in sepsis and septic shock.
  • To explore the potential of Gas6 as a diagnostic, prognostic, and therapeutic agent.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of studies focusing on the Gas6/TAM axis in inflammation and sepsis.
  • Synthesis of findings on biomarker and therapeutic potential.

Main Results:

  • The Gas6/TAM axis plays a pivotal role in sepsis-related inflammatory responses.
  • Alterations in Gas6 or TAM expression can lead to pathological conditions.
  • Gas6 is involved in maintaining homeostasis and regulating inflammation.

Conclusions:

  • The Gas6/TAM axis is significantly implicated in sepsis pathogenesis and progression.
  • Gas6 shows promise as a diagnostic and prognostic biomarker for systemic acute conditions.
  • Targeting the Gas6/TAM pathway may offer therapeutic strategies for sepsis and septic shock.

Related Concept Videos

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice04:01

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice

This murine model combines a septic insult with hindlimb muscle disuse to recapitulate the bedridden feature of the typical septic patient. The model represents a significant departure from previous models to study muscle dysfunction in sepsis and is a reproducible approach to addressing therapeutic strategies to treat this...
1.4K
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Neutrophils are the most abundant type of white blood cells. The isolation of neutrophils from human blood by density gradient separation method and the differentiation of human promyelocytic (HL60) cells along the granulocytic pathway are described here; to test their role on sensitivity of lymphoma cells to anti-lymphoma agents.
15.8K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.6K
A Data-Driven Approach to Quantifying Immune States in Sepsis07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

This study investigates the immune condition in sepsis by analyzing the quantitative relationships among white blood cells, lymphocytes, and neutrophils in sepsis patients and healthy controls using data visualization analysis and three-dimensional numerical fitting to establish a mathematical model.
482
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

This protocol describes the in vitro comparison of two key functional characteristics of rituximab: target binding and complement-dependent cytotoxicity (CDC) induction. The methods were employed for a side-to-side comparison between reference rituximab and a rituximab biosimilar. These assays can be employed during biosimilar development or as a quality control in their...
18.2K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

6.2K